Back
Corteva, Inc. (CTVA)
ChemicalsCTVA · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$83.86
−1.57%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$1.61
ROE
5.1%
Gross margin
48.6%
Debt/Equity
0.14x
Revenue growth
11.0%
Corteva, Inc. — company intelligence
Earnings surprises
Q1 2026$1.50 vs $1.20 est+25.4%
Q4 2025$0.22 vs $0.22 est-2.1%
Q3 2025$-0.23 vs $-0.54 est+57.6%
Q2 2025$2.20 vs $1.93 est+14.1%
Insider activity · 90 days
14 buys2 sellsnet +50,193 shares
KISSAM LUTHER C IVBuy 24,138 · Jun 1, 2026
Nayyar Nayaki RBuy 401 · Apr 30, 2026
Engel Klaus ASell 906 · Apr 30, 2026
Recent SEC filings
8-K — Material event reportJun 29, 2026
4 — Insider transaction reportJun 3, 2026
10-Q — Quarterly reportMay 6, 2026
Latest news
Is Corteva (CTVA) Stock Rich Or Reasonable As Breakups Near? — Yahoo · 6d ago
How Adding Arginex Soy to Seed Treatments at Corteva (CTVA) Has Changed Its Investment Story — Yahoo · 1w ago
Corteva and Arevo Partner on Soy Crop Nutrition — Yahoo · 1w ago
Can the Blueberries Segment Accelerate Mission Produce's Growth? — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Corteva, Inc.
Weekly undervalued picks (like CTVA)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.